Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Suspended 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Prostatic Neoplasms 4 Burkitt Lymphoma 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 2 Hodgkin Disease 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmablastic Lymphoma 1 Neuroblastoma 1 Lymphoma, T-Cell 1 Lymphoma, Primary Effusion 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Leukemia, Biphenotypic, Acute 1 Immunoblastic Lymphadenopathy 1 HIV Infections 1 Enteropathy-Associated T-Cell Lymphoma 1 Composite Lymphoma 1 Blast Crisis 1

Interventions

Cyclophosphamide 282 Rituximab 260 Etoposide 161 Filgrastim 155 Vincristine 145 Doxorubicin 134 Prednisone 117 Cytarabine 108 Radiotherapy 102 Peripheral Blood Stem Cell Transplantation 90 Methotrexate 90 fludarabine phosphate 87 Melphalan 78 Busulfan 71 Dexamethasone 59 Granulocyte Colony-Stimulating Factor 56 Carmustine 53 fludarabine 51 Bortezomib 46 Tacrolimus 44 Mycophenolic Acid 41 Antilymphocyte Serum 41 Ifosfamide 40 Leucovorin 39 Gemcitabine 38 Whole-Body Irradiation 36 Cyclosporine 35 Bendamustine Hydrochloride 34 sargramostim 33 Methylprednisolone 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma × prednylidene × Clear all

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡